On Wednesday, Shares of EnteroMedics Inc (NASDAQ: ), added 5.45% and closed at $0.132 in the last trading session. The last trading range of the stock ranges between $0.13 and $0.14. The company’s Market capitalization is $8.40 million with the total Outstanding Shares of 69.70 million. EnteroMedics Inc. (ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, recently declared that vBloc® Neurometabolic Therapy is now available to U.S. veterans at U.S. Department of Veterans Affairs (VA) medical facilities. This is made possible through the formerly-declared EnteroMedics partnership with Academy Medical, LLC, a certified Service-Disabled Veteran-Owned Small Business specializing in the distribution of medical products to VA and Department of Defense (DoD) facilities. As of October 1, 2016, vBloc was added to Academy Medical’s five year sole source agreement with the U.S. Department of Veterans Affairs that allows any VA surgeon in the U.S. to purchase the vBloc System from Academy Medical under a national contract.
“VA surgeons across the U.S. now have access to a safe and effective treatment option for obesity,” said Sachin Kukreja, M.D., Director, Bariatric Surgery, VA North Texas Health Care System. “Our center has extensive experience and success with vBloc Therapy and we look forward to expanding the reach of this exciting new treatment to eligible obese patients who do not wish to undergo anatomy-altering, restrictive surgeries.”
“We are very happy that VA surgeons now have the ability to treat over one million eligible veterans fighting obesity with vBloc Therapy,” said Dan Gladney, EnteroMedics’ President and Chief Executive Officer. “The veterans of our armed services, in addition to all patients, deserve access to every option that may assist in their battle against obesity. We look forward to working closely with the VA and Academy Medical to train VA surgeons so they are prepared to offer vBloc Therapy and perform implants as soon as possible.”
General Mills, Inc. (NYSE:GIS), dropped -0.34% and closed at $62.36 in the last trading session. The last trading range of the stock ranges between $62.03 and $62.88. The company’s Market capitalization is $36.40 Billion with the total Outstanding Shares of 591.38 million. The General Mills Board of Directors recently declared a quarterly dividend at the prevailing rate of $0.48 per share, payable November 1, 2016, to shareholders of record as of October 10, 2016. General Mills (GIS) current annualized dividend rate of $1.92 per share represents a boost of 8 percent over the annual dividend of $1.78 paid in fiscal 2016.
In actions at the company’s 88th annual meeting held recently in Minneapolis, shareholders elected the 13 directors nominated, approved the compensation plan for non-employee directors, cast an advisory vote approving the company’s compensation for its named executive officers, and ratified the appointment of KPMG LLP as the company’s independent auditor for fiscal 2017.
WhiteWave Foods Co (NYSE:WWAV), lost -0.29% and closed at $54.60 in the last trading session. The last trading range of the stock ranges between $4.56 and $54.85. During the 52-week trading session the minimum price at which share price traded, registered at $31.40 and reached to max level of $56.82. The WhiteWave Foods Company (WWAV) (“WhiteWave”), a leading consumer packaged food and beverage company in North America and Europe, declared that during a special stockholder meeting recently the stockholders of the company approved the merger agreement under which Danone S.A. (“Danone”) will acquire all of the outstanding shares of WhiteWave. Stockholders also approved other proposals regardingthe merger.
Holders of about 99 percent of shares present and voting at the meeting, representing about 78 percent of WhiteWave’s total outstanding shares, voted in favor of a proposal to approve the merger agreement. The final vote results will be stated in a Form 8-K that WhiteWave will file with the Securities and Exchange Commission.
“Recently’s vote brings us one step closer to combining two strong, values-based, purpose-driven companies. We are grateful for the continued enthusiasm and support of the transaction by our stockholders,” said Gregg Engles, WhiteWave’s Chairman and Chief Executive Officer. “We believe that WhiteWave’s mission to change the way the world eats for the better dovetails nicely with Danone’s mission to bring health through food to as many people as possible. Danone is the ideal planned partner to support our future and we remain excited about the opportunities this combination will create for WhiteWave’s employees, customers, vendors and partners.”